Global Uro-Gynaecological Surgical Devices Market

Global Uro-Gynaecological Surgical Devices Market size was valued at USD 9.31 Bn. in 2024 and the total Global Uro-Gynaecological Surgical Devices Market revenue is expected to grow at a CAGR of 9.3% from 2025 to 2032, reaching nearly USD 18.96 Bn. by 2032.

Global Uro-Gynaecological Surgical Devices Market Overview

Uro-gynaecological surgical devices are medical instruments used in surgical procedures to treat conditions related to the female pelvic floor and urinary tract, often involving repair of pelvic organ prolapse.

Global Uro-Gynaecological Surgical Devices Market has been growing by increasing demand from urologists, gynecologists, hospital administrators and specialized surgical centers. Growing focus on enhanced pelvic health, quality of life improvements and long lasting minimally invasive treatment solutions is accelerating market adoption. Expanding applications of uro gynaecological surgical devices across stress urinary incontinence (SUI), pelvic organ prolapse (POP), hysterectomy procedures and reconstructive pelvic surgeries are reshaping traditional treatment approaches and supporting rise of modern, tech integrated surgical care. Technological advancements such as next generation mesh materials, robotic assisted laparoscopic systems, AI driven surgical planning and real time intraoperative imaging are enhancing the precision, safety and personalization of uro-gynaecological interventions. Market is further supported by rising healthcare expenditure, increased awareness of pelvic health among aging female populations and global shift toward outpatient and day care based minimally invasive procedures. North America dominated uro-gynaecological surgical devices market, driven by region’s advanced healthcare infrastructure, high per capita healthcare spending, rapid adoption of surgical robotics and established reimbursement systems. Key players in Uro-Gynaecological Surgical Devices Market include Boston Scientific Corporation, Coloplast Group and Medtronic plc. Companies are focusing on biocompatible and lightweight implant materials, expanding robotic assisted surgery solutions, forging hospital partnerships and investing in safe, evidence based and regulatory compliant uro gynaecological innovations to meet growing global demand.

Report covers uro-gynaecological surgical devices market dynamics, structure by analyzing market segments and projecting Global uro-gynaecological surgical devices market size. Clear representation of competitive analysis of key players By Procedure, price, financial position, product portfolio, growth strategies and regional presence in Global uro-gynaecological surgical devices market.To know about the Research Methodology :- Request Free Sample Report

Global Uro-Gynaecological Surgical Devices Market Dynamics

Minimally Invasive Gynaecological Procedures to Boost Global Uro-Gynaecological Surgical Devices Market

Increasing acceptance of minimally invasive surgical procedures like Endometrial Ablation, myomectomy, and hysteroscopy are set to enhance the demand for Uro-Gynecological surgical devices in the forecast period. The fact that millions of women worldwide suffer from urological disorders are not diagnosed adequately will drive the market growth. Nearly 50 million women worldwide suffer from urinary incontinence, due to pelvic floor damage during pregnancy and childbirth. Rapidly increasing geriatric population globally is also likely to drive the market over the next few years.

Endometrial Ablation is gaining prominence worldwide as an effective treatment procedure for reducing heavy bleeding disorders in women. Besides this, other factors such as the increasing cases of gynecological issues, improving regulatory framework, growing research funding, unmet medical needs, rising competition among market players, the increasing number of gynecology surgeries, emerging Asian markets, and increasing government assistance are continuously contributing to the growth of the global gynecological devices and instruments market.

Despite of these drivers, high cost of treatment, lack of skilled professionals, and the poor healthcare system in underdeveloped and middle- income economies may hamper the market growth during the forecast period.

Global Uro-Gynaecological Surgical Devices Market Segment Analysis

Based on disease-specific surgeries, the market is segmented into pelvic organ prolapse, urinary incontinence, others. The pelvic organ prolapse segment dominated the uro-gynaecological surgical devices market in 2024. Pelvic organ prolapse is when 1 or more organs in the pelvis slip down from their normal position and bulge into the vagina. The surgery attaches the vaginal vault to the sacrum with surgical mesh. The lifetime risk of a woman for POP surgery is estimated to be 19% and the reoperation risk even with an appropriate surgery is about 30%. The incidence of pelvic organ prolapse surgery is 2-3 per 1000 women and peaks in women aged between 60 to 69. The pelvic organ prolapse surgery market estimated the value of $537.2 Mn in 2021. occupying a larger market share of more than 50%.

Global Uro-Gynaecological Surgical Devices Market Regional Insights

North America dominated the Global Uro-Gynaecological Surgical Devices Market in 2024 and is expected to dominate the market share of xx% during the forecast period (2025-2032)

Market growth in the US is mainly driven by the factors like increasing aging population, advanced technology-based devices, and acceptance of minimally invasive surgeries makes the US an undeniable market leader. Europe is expected to hold the second-largest market share owing to the rising prevalence of ovarian cancer and mortality rates. Due to ovarian cancer, 184,799 deaths occurred in 2022 which resulted in 4.4% of the total cancer-associated mortality among females. APAC is expected to witness lucrative growth in the forecast period owing to the increasing awareness and better diagnosis & surgical procedures.

Global Uro-Gynaecological Surgical Devices Market Competitive Landscape

Top key players in the uro-gynaecological surgical devices market include Boston Scientific Corporation, Coloplast Group and Medtronic plc. Companies are focused on innovation in implantable materials, advanced surgical delivery systems and development of safe, durable and minimally invasive solution for treatment of pelvic floor disorders. Manufacturers are producing cost effective and patient-friendly surgical devices that are used in hospitals, ambulatory surgical centers and specialty clinics, targeting faster recovery, procedural precision and improved outcomes. Boston Scientific is known for its leadership in pelvic floor health and minimally invasive treatment solutions, offering broad range of mid urethral slings, bulking agents and sacral neuromodulation systems. Company emphasizes clinical safety, procedural efficiency and enhanced patient comfort, supported by strong surgeon training and global regulatory compliance. Coloplast Group focuses on biocompatible implant materials and user centric device design, delivering uro-gynaecological surgical solutions that minimize surgical trauma and improve functional recovery.

Global Uro-Gynaecological Surgical Devices Market Trends

• Rising Adoption of Minimally Invasive Procedures
Increasing preference for procedures like endometrial ablation, laparoscopic hysterectomy, and robotic myomectomy is driving demand for precision surgical tools with shorter recovery times and reduced complications.

• Shift Toward Outpatient and Day-Care Surgeries
Hospitals and surgical centers are increasingly adopting same-day discharge procedures to reduce costs and improve patient satisfaction, boosting demand for easy-to-use, efficient uro-gynaecological devices.

• Technological Advancements in Surgical Tools
Innovations such as robotic-assisted systems, AI-guided surgical navigation, and advanced mesh implants are enhancing surgical accuracy, safety, and outcomes in pelvic reconstructive surgeries.

Global Uro-Gynaecological Surgical Devices Market Recent Development

• On April 26, 2025, Medtronic plc (U.S) Expand URO U.S. clinical study met primary safety and effectiveness endpoints for its Hugo robotic-assisted surgery system in urologic procedures, in a 137 patient, multi center IDE study presented at the American Urological Association meeting.

• On April 30, 2025, Coloplast Group (Denmark) showcased multiple innovations and initiatives via LinkedIn, including the launch of a new SpeediCath hydrophilic catheter for women, enhancements in uro-gynaecological care and online professional education modules globally.

Uro-Gynaecological Surgical Devices Market Scope: Inquire before buying

Global Uro-Gynaecological Surgical Devices Market, by Region

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Global Uro-Gynaecological Surgical Devices Market Key Players

North America

1. Boston Scientific Corporation (USA)
2. Medtronic plc (USA)
3. CooperSurgical Inc. (USA)
4. Hologic, Inc. (USA)
5. Cook Medical LLC (USA)
6. Bright Uro (USA)
7. Becton, Dickinson and Company – BD (USA)
8. Caldera Medical (USA)
9. UroCure (USA)

Europe

10. Coloplast Group (Denmark)
11. Richard Wolf GmbH (Germany)
12. Karl Storz SE & Co. KG (Germany)
13. B. Braun Melsungen AG (Germany)
14. Promedon GmbH (Germany)
15. LABORIE Medical Technologies (France)
16. ZSI Surgical Implants (Switzerland)
17. MedGyn Products Europe (Netherlands)
18. A.M.I. GmbH (Austria)
19. Neomedic International (Spain)

Asia-Pacific

20. Olympus Corporation (Japan)
21. Stryker Japan K.K. (Japan)
22. Harsoria Healthcare Pvt. Ltd. (India)
23. Narang Medical Limited (India)
24. EndoMed Systems (South Korea)
25. Shanghai Kindly Medical Instruments (China)
26. Suzhou Sunmed Co., Ltd. (China)
27. STERIS India Pvt. Ltd. (India)
28. Changzhou Ankang Medical Instruments (China)
29. Dawei Medical (China)

FAQs:

1. Which region has the largest share in the Uro-Gynaecological Surgical Devices Market?
Ans: The North America region held the highest share in 2024 in the Uro-Gynaecological Surgical Devices Market.

2. What are the key factors driving the growth of the Uro-Gynaecological Surgical Devices Market?
Ans: Minimally invasive gynaecological procedures to boost the Uro-Gynaecological Surgical Devices Market growth.

3. Who are the key competitors in the Uro-Gynaecological Surgical Devices Market?
Ans: Boston Scientific Corporation, Coloplast Group, and Medtronic plc are the key competitors in the Uro-Gynaecological Surgical Devices Market.

4. What are the opportunities for the Uro-Gynaecological Surgical Devices Market?
Ans: Technological Innovation in Implants and Devices create opportunities in the Uro-Gynaecological Surgical Devices Market.

5. Which disease specific surgeries segment dominates the Uro-Gynaecological Surgical Devices Market?
Ans: The pelvic organ prolapse segment dominated the Uro-Gynaecological Surgical Devices Market.